2004
DOI: 10.1073/pnas.0401028101
|View full text |Cite
|
Sign up to set email alerts
|

QSulf1, a heparan sulfate 6- O -endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

12
152
1
2

Year Published

2006
2006
2016
2016

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 184 publications
(167 citation statements)
references
References 43 publications
12
152
1
2
Order By: Relevance
“…It has already been reported that de-sulfation of HSPG accounts for altered function. For example, avian QSULF1, a family member of Sulf2, inhibited angiogenesis in vitro [33]. Analogously, desulfation triggered by insulin via Sulf2 may induce functional changes in adipocytes.…”
Section: Discussionmentioning
confidence: 99%
“…It has already been reported that de-sulfation of HSPG accounts for altered function. For example, avian QSULF1, a family member of Sulf2, inhibited angiogenesis in vitro [33]. Analogously, desulfation triggered by insulin via Sulf2 may induce functional changes in adipocytes.…”
Section: Discussionmentioning
confidence: 99%
“…Specific sulfate groups (6S) have been shown to be dispensable for FGF2-HS binding, but critical for FGF/ FGFR2 signalling (Ishihara et al, 1995), and therefore removal of the 6-O-sulfate group disrupts FGF signalling (Wang et al, 2004). Similarly, VEGF binding and activity requires moderately 6-O sulfated HS (Ashikari-Hada et al, 2005;Robinson et al, 2006) and treatment of heparin with human SULF2 abolishes its binding to VEGF (Uchimura et al, 2006).…”
Section: Introductionmentioning
confidence: 99%
“…HS 6-O-endosulfatases remove sulfate groups from specific positions along the HS chain. 6-O-sulfatase activity inhibits FGF signaling but has an opposing effect on WNT signaling Wang et al, 2004).…”
Section: Introductionmentioning
confidence: 99%